Literature DB >> 4358857

Antibody to viruses affecting cattle in commercial tissue culture grade fetal calf serum.

C R Rossi, G K Kiesel.   

Abstract

Commercial fetal calf serum (FCS) for tissue culture use was tested for neutralizing activity against several viruses which affect cattle. Certain lots of FCS contained no neutralizing activity, whereas other lots contained neutralizing activity to several viruses. It was concluded that the neutralizing activity found in certain lots of sera was due to specific antibody and that its presence could be most easily explained by the contamination of the FCS with serum from postcolostral bovine serum. A nonantibody inhibitor to vesicular stomatitis virus was also found at low levels in most lots of serum. Because those sera which had antibody had antibody to several viruses, it was suggested that the use of the micro-serum neutralization test with a few bovine viruses which are widespread in the bovine population should be satisfactory to detect FCS which was contaminated with postcolostral bovine serum.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4358857      PMCID: PMC379977          DOI: 10.1128/am.27.1.114-117.1974

Source DB:  PubMed          Journal:  Appl Microbiol        ISSN: 0003-6919


  13 in total

1.  ABORTION EXPERIMENTALLY INDUCED IN CATTLE BY INFECTIOUS BOVINE RHINOTRACHEITIS VIRUS.

Authors:  T L CHOW; J A MOLELLO; N V OWEN
Journal:  J Am Vet Med Assoc       Date:  1964-05-01       Impact factor: 1.936

2.  A serological study of bovine foetal immunoglobulins.

Authors:  G W Horner; R H Johnson; D P Dennett; W R Lane
Journal:  Aust Vet J       Date:  1973-07       Impact factor: 1.281

3.  Observations on latent bluetongue virus infection in cattle.

Authors:  A J Luedke; M M Jochim; J G Bowne; R H Jones
Journal:  J Am Vet Med Assoc       Date:  1970-06-15       Impact factor: 1.936

4.  Serologic evidence of an etiologic role for bluetongue virus in hydranencephaly of calves.

Authors:  D G McKercher; J K Saito; K V Singh
Journal:  J Am Vet Med Assoc       Date:  1970-04-15       Impact factor: 1.936

5.  Gamma-globulin foetal bovine sera: significance in virology.

Authors:  A J Kniazeff; V Rimer; L Gaeta
Journal:  Nature       Date:  1967-05-20       Impact factor: 49.962

6.  Ontogeny of the bovine immune response.

Authors:  R D Schultz; H W Dunne; C E Heist
Journal:  Infect Immun       Date:  1973-06       Impact factor: 3.441

7.  Bluetongue disease in cattle.

Authors:  J G Bowne; A J Luedke; M M Jochim; H E Metcalf
Journal:  J Am Vet Med Assoc       Date:  1968-09-15       Impact factor: 1.936

8.  Evaluation of the demonstration of complement-requiring neutralizing antibody as a means for early diagnosis of herpes virus infections.

Authors:  K Yoshino; S Taniguchi
Journal:  J Immunol       Date:  1966-02       Impact factor: 5.422

9.  Viral infection of the bovine fetus and its environment.

Authors:  W T Hubbert; J H Bryner; A L Fernelius; G H Frank; P C Estes
Journal:  Arch Gesamte Virusforsch       Date:  1973

10.  Bovine viral diarrhea-mucosal disease virus infection in pregnant cows.

Authors:  J W Kendrick
Journal:  Am J Vet Res       Date:  1971-04       Impact factor: 1.156

View more
  4 in total

1.  Effect of fetal bovine serum on foamy and lentiviral vector production.

Authors:  John M Powers; Grant D Trobridge
Journal:  Hum Gene Ther Methods       Date:  2013-08-28       Impact factor: 2.396

2.  Methods for the detection of viruses in bovine serum.

Authors:  N S Swack; C K Fong; G D Hsiung; P A Gross
Journal:  J Clin Microbiol       Date:  1975-02       Impact factor: 5.948

3.  Serological evidence for the association of bovine respiratory syncytial virus with respiratory tract disease in Alabama cattle.

Authors:  C R Rossi; G K Kiesel
Journal:  Infect Immun       Date:  1974-08       Impact factor: 3.441

4.  Bovine respiratory syncytial virus infection of bovine embryonic lung cultures: enhancement of infectivity with diethylaminoethyl-dextran and virus-infected cells.

Authors:  C R Rossi; G K Kiesel
Journal:  Arch Virol       Date:  1978       Impact factor: 2.574

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.